Edward V. Lally

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

Philip J. Clements, Daniel E. Fürst, Weng Kee Wong et al. · Arthritis & Rheumatism · 1999 · 331 citations

Medicine, Dermatology, Pharmacotherapy +13

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial

Philip J. Clements, Eric L. Hurwitz, Weng Kee Wong et al. · Arthritis & Rheumatism · 2000 · 287 citations

Medicine, Clinical Sciences, Dermatology +15

Predictors and outcomes of scleroderma renal crisis: The high‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis trial

Paul J. DeMarco, Michael H. Weisman, James R. Seibold et al. · Arthritis & Rheumatism · 2002 · 224 citations

Medicine, Clinical Sciences, Pharmacotherapy +12

Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study

Dinesh Khanna, Daniel E. Furst, Ron D. Hays et al. · Annals of the Rheumatic Diseases · 2006 · 151 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Correlates of the disability index of the health assessment questionnaire: A measure of functional impairment in systemic sclerosis

Philip J. Clements, Weng Kee Wong, Eric L. Hurwitz et al. · Arthritis & Rheumatism · 1999 · 113 citations

Medicine, Pharmacotherapy, Immunopathology +10